These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 9154322)

  • 21. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
    Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
    Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
    Wurch T; Palmier C; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [35S]GTPgammaS binding responses.
    Dupuis DS; Perez M; Halazy S; Colpaert FC; Pauwels PJ
    Brain Res Mol Brain Res; 1999 Apr; 67(1):107-23. PubMed ID: 10101238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519.
    Longmore J; Boulanger CM; Desta B; Hill RG; Schofield WN; Taylor AA
    Br J Clin Pharmacol; 1996 Oct; 42(4):431-41. PubMed ID: 8904614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-694,247: a potent 5-HT1D receptor agonist.
    Beer MS; Stanton JA; Bevan Y; Heald A; Reeve AJ; Street LJ; Matassa VG; Hargreaves RJ; Middlemiss DN
    Br J Pharmacol; 1993 Nov; 110(3):1196-200. PubMed ID: 8298808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
    Jähnichen S; Radtke OA; Pertz HH
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):54-63. PubMed ID: 15185063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.
    Storer RJ; Goadsby PJ
    Brain; 1997 Dec; 120 ( Pt 12)():2171-7. PubMed ID: 9448572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
    Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
    Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats.
    Cumberbatch MJ; Hill RG; Hargreaves RJ
    Eur J Pharmacol; 1998 Nov; 362(1):43-6. PubMed ID: 9865528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation.
    Razzaque Z; Heald MA; Pickard JD; Maskell L; Beer MS; Hill RG; Longmore J
    Br J Clin Pharmacol; 1999 Jan; 47(1):75-82. PubMed ID: 10073743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL; Goadsby PJ
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bovine isolated middle cerebral artery contractions to antimigraine drugs.
    Roon KI; Maassen Van Den Brink A; Ferrari MD; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):591-6. PubMed ID: 10598799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater.
    Yu XJ; Cutrer FM; Moskowitz MA; Waeber C
    Neuropharmacology; 1997 Jan; 36(1):83-91. PubMed ID: 9144644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine.
    Bou J; Domènech T; Puig J; Heredia A; Gras J; Fernández-Forner D; Beleta J; Palacios JM
    Eur J Pharmacol; 2000 Dec; 410(1):33-41. PubMed ID: 11134654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zolmitriptan stimulates a Ca(2+)-dependent K(+) current in C6 glioma cells stably expressing recombinant human 5-HT(1B) receptors.
    Le Grand B; Panissié A; Perez M; Pauwels PJ; John GW
    Eur J Pharmacol; 2000 Jun; 397(2-3):297-302. PubMed ID: 10844127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor.
    Gupta P; Scatchard J; Napier C; McHarg A; Wallis R
    Eur J Pharmacol; 1999 Feb; 367(2-3):283-90. PubMed ID: 10079003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
    Williamson DJ; Hill RG; Shepheard SL; Hargreaves RJ
    Br J Pharmacol; 2001 Aug; 133(7):1029-34. PubMed ID: 11487512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
    Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM
    Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT
    Edvinsson JCA; Maddahi A; Christiansen IM; Reducha PV; Warfvinge K; Sheykhzade M; Edvinsson L; Haanes KA
    J Headache Pain; 2022 Feb; 23(1):26. PubMed ID: 35177004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of binding, functional activity, and contractile responses of the selective 5-HT
    Rubio-Beltrán E; Labastida-Ramírez A; Haanes KA; van den Bogaerdt A; Bogers AJJC; Zanelli E; Meeus L; Danser AHJ; Gralinski MR; Senese PB; Johnson KW; Kovalchin J; Villalón CM; MaassenVanDenBrink A
    Br J Pharmacol; 2019 Dec; 176(24):4681-4695. PubMed ID: 31418454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.